Informations cliniques
Les collagénoses sont des maladies rhumatismales. Il s’agit par exemple du lupus érythémateux disséminé, de la sclérodermie systémique, du syndrome de Sjögren, des syndromes de myosite ou du syndrome de Sharp.
Les auto-anticorps dirigés contre des composants cellulaires, généralement appelés anticorps anti-nucléaires (ANA), constituent un marqueur sérologique important des collagénoses. Les antigènes cibles comprennent par exemple les acides nucléiques, les protéines du noyau cellulaire et les ribonucléoprotéines, mais aussi des composants du cytoplasme.
La fréquence (prévalence) des anticorps anti-nucléaires dans les maladies rhumatismales inflammatoires se situe entre 20 % et 100 %. Par conséquent, un diagnostic différencié des ANA est indispensable pour identifier les différentes maladies rhumatismales et les distinguer des autres maladies auto-immunes.
Diagnostic
La méthode de référence pour la détection des ANA est le test d’immunofluorescence indirecte (IFI) avec des cellules épithéliales humaines (HEp-2), connu pour sa grande sensibilité et spécificité. L’évaluation au microscope permet de déterminer avec précision comment un colorant indicateur (généralement la fluorescéine) se répartit dans les cellules. En fonction de la localisation des différents autoantigènes, chaque type d’auto-anticorps lié donne un aspect de fluorescence typique.
Le consensus international révisé sur une nomenclature standardisée des aspects des cellules HEp-2 en immunofluorescence indirecte (ICAP, www.anapatterns.org) définit 15 aspects nucléaires, 9 aspects cytoplasmiques et 5 aspects mitotiques pertinents pour le diagnostic de diverses maladies auto-immunes.
En outre, l’ICAP recommande d’effectuer d’autres tests d’anticorps spécifiques (par exemple ELISA, immunoblot, ChLIA) pour confirmer les résultats en IFI. La seule utilisation de ces méthodes de test monospécifiques ne suffit cependant pas pour déterminer les auto-anticorps anti-noyaux cellulaires, car tous les antigènes pertinents ne sont pas encore disponibles sous forme purifiée et les ANA correspondants ne peuvent donc être detectés que par IFI.
| Technology | Parameter | Substrate | Species | Calibration | Ig Class | Format | Order No. |
|---|---|---|---|---|---|---|---|
| IIFT | cell nuclei (ANA) |
HEp-2 cells (1 BIOCHIP per field) |
human | IgG IgG IgG IgG |
10 x 50 120 x 10 20 x 05 20 x 10 |
FA 1520-1050-R FA 1520-12010-R FA 1520-2005-R FA 1520-2010-R |
|
| IIFT | cell nuclei (ANA) |
HEp-20-10 cells (1 BIOCHIP per field) |
human | IgG IgG IgG IgG |
10 x 50 120 x 10 20 x 05 20 x 10 |
FA 1522-1050-R FA 1522-12010-R FA 1522-2005-R FA 1522-2010-R |
|
| ELISA | Anti-PM-Scl-ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in E. coli |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1584-9601 G |
| ELISA | Anti-nRNP/Sm ELISA (IgG) |
antigen-coated microplate wells |
native, U1-nRNP, incl. 70K, A, C, B, B', D, E, F, G, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1591-9601 G |
| ELISA | Anti-Jo-1 ELISA (IgG) |
antigen-coated microplate wells |
native, histidyl-tRNA synthetase, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1661-9601 G |
| ELISA |
Anti-cN-1A ELISA (IgG) Mup44, NT5C1A |
antigen-coated microplate wells |
recombinant, expression in E. coli | semi-quantitative | IgG |
48 x 01 |
EA 1675-4801 G |
| EUROLINE |
EUROLINE Myositis Antigens Profile (IgG) (Mi-2, Ku, PM-Scl, Jo-1, PL-7, PL-12, Ro-52 separately) |
EUROLINE | IgG |
16 x 01 |
DL 1530-1601 G | ||
| EUROLINE |
EUROLINE Myositis Antigens Profile 3 (IgG) (Mi-2, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-3 G DL 1530-5001-3 G DL 1530-6401-3 G |
||
| EUROLINE |
EUROLINE Autoimmune Inflammatory Myopathies 16 Ag (IgG) (Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-4 G DL 1530-5001-4 G DL 1530-6401-4 G |
||
| EUROLINE |
EUROLINE Autoimmune Inflammatory Myopathies 16 Ag et cN-1A (IgG) (Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, cN-1A separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-7 G DL 1530-5001-7 G DL 1530-6401-7 G |
||
| EUROLINE |
EUROLINE Autoimmune Inflammatory Myopathies 20 Ag (IgG) ( Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, cN-1A, Ha, Ks, Zo) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-9 G DL 1530-5001-9 G DL 1530-6401-9 G |
||
| ChLIA | IDS Jo-1 | antigenic coated magnetic particles | Jo-1 |
quantitative |
50 x 01 |
IS-AI11091 | |
| ChLIA | IDS SS-A/Ro 52 kDa | antigenic coated magnetic particles | SS-A/Ro 52 kDa |
quantitative |
50 x 01 |
IS-AI11031 | |
| ChLIA | CRP | immunoturbidimetric assay |
quantitative |
01 x 190 |
CPTXL-H00/IDS1 | ||
| ELISA |
Anti-ssDNA ELISA (IgG) single-stranded DNA |
antigen-coated microplate wells |
heat-denatured ssDNA | 2/20/200 RU/ml | IgG |
96 x 01 |
EA 1576-9601 G |
| ELISA |
Anti-ENA ProfilePlus 1 ELISA (IgG) (nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1 separately) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
12 x 08 |
EA 1590-1208-1 G |
| ELISA |
Anti-ENA PoolPlus ELISA (IgG) (antigen mixture: nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-7 G |
| ELISA |
Anti-SS-A ELISA (IgG) Ro |
antigen-coated microplate wells |
native, SS-A-specific proteins (60 kDa), calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1595-9601 G |
| ELISA |
Anti-SS-B ELISA (IgG) La |
antigen-coated microplate wells |
native, SS-B-specific protein (48 kDa), calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1597-9601 G |
| ELISA | Anti-Scl-70 ELISA (IgG) |
antigen-coated microplate wells |
native, DNA topoisomerase I, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1599-9601 G |
| ELISA | Anti-DFS70 ELISA (IgG) |
antigen-coated microplate wells |
DFS70 recombinant |
semi-quantitative | IgG |
96 x 01 |
EA 159z-9601 G |
| ELISA | Anti-Centromeres ELISA (IgG) |
antigen-coated microplate wells |
recombinant centromere protein B, expression with baculovirus vector in insect cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1611-9601 G |
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1530-X G |
IgG |
05 x 07 |
CL 1530-0507 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1532 G |
IgG |
05 x 07 |
CL 1532-0507 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1590-X G |
IgG |
05 x 07 |
CL 1590-0507 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1590-35 G |
IgG |
05 x 07 |
CL 1590-0507-35 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 159z-X G |
IgG |
05 x 07 |
CL 159z-0507 G | |||
| EUROLINE |
EUROLINE Systemic sclerosis (Nucleoli) profile (IgG) (Scl-70, CENP A, CENP B, RP11, RP155, fibrillarin, NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, PDGFR, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1532-1601 G DL 1532-5001 G DL 1532-6401 G |
||
| EUROLINE |
EUROLINE Systemic Sclerosis Profile 2 (IgG) (Scl-70, CenpA, Cenp B, RP11, RP155, Fibrillarin, NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, NVL und Ro-52) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1532-1601-2 G DL 1532-5001-2 G DL 1532-6401-2 G |
||
| EUROLINE |
EUROLINE Anti-ENA ProfilePlus 1 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1 separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-1 G DL 1590-6401-1 G |
||
| EUROLINE |
EUROLINE Anti-ENA ProfilePlus 2 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1, ribosomal P-proteins separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-2 G DL 1590-6401-2 G |
||
| EUROLINE | EUROLINE Anti-dsDNA, -Nucleosomes, -Histones, -DFS70 (IgG) | EUROLINE | IgG IgG |
16 x 01 50 x 01 |
DL 1590-1601-32 G DL 1590-5001-32 G |
||
| EUROLINE |
EUROLINE Cytoplasm profile (IgG) (AMA M2, M2-3E, ribosomal P-proteins, Jo-1 SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-35 G DL 1590-5001-35 G DL 1590-6401-35 G |
||
| EUROLINE |
EUROLINE Cytoplasm profile 13 Ag (IgG) (CAMA-M2, M2-3E, ribosomal P-Proteins, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, Ha, Ks, Zo separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-37 G DL 1590-5001-37 G DL 1590-6401-37 G |
||
| EUROLINE | EUROLINE Anti-DFS70 (IgG) | EUROLINE | IgG IgG |
16 x 01 50 x 01 |
DL 159z-1601 G DL 159z-5001 G |
||
| EUROASSAY |
EUROASSAY Anti-ENA ProfilePlus (IgG) (nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1 separately) |
EUROASSAY strip with antigens |
IgG IgG |
DA 1590-1003-1 G DA 1590-1005-1 G |
|||
| ChLIA | IDS Scl-70 | antigenic coated magnetic particles | Scl-70 |
quantitative |
50 x 01 |
IS-AI11081 | |
| ChLIA | IDS Centromere B | antigenic coated magnetic particles | Centromere B |
quantitative |
50 x 01 |
IS-AI11101 | |
| IIFT |
antibodies against cell nuclei (ANA control), homogeneous pattern |
IgG |
05 x 02 |
CA 1570-0502 | |||
| IIFT |
antibodies against dsDNA (dsDNA ab control) |
IgG |
05 x 02 |
CA 1572-0502 | |||
| IIFT |
cell nuclei (ANA global test) |
HEp-2 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG IgG IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1510-1005-1 FA 1510-1010-1 FA 1510-1050-1 FA 1510-12010-1 FA 1510-2005-1 FA 1510-2010-1 FA 1510-2450-1 FB 1510-1005-1 FB 1510-1010-1 FB 1510-1050-1 FB 1510-2005-1 FB 1510-2010-1 |
|
| IIFT |
cell nuclei (ANA) mitochondria (AMA) |
HEp-2 cells kidney (2 BIOCHIPs per field) |
human rat |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1510-1005-2 FA 1510-1010-2 FB 1510-1005-2 FB 1510-1010-2 |
|
| IIFT |
cell nuclei (ANA global test) |
HEp-20-10 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG IgG IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1512-1005-1 FA 1512-1010-1 FA 1512-1050-1 FA 1512-12010-1 FA 1512-2005-1 FA 1512-2010-1 FA 1512-2450-1 FB 1512-1005-1 FB 1512-1010-1 FB 1512-1050-1 FB 1512-2005-1 FB 1512-2010-1 |
|
| IIFT |
cell nuclei (ANA) mitochondria (AMA) |
HEp-20-10 cells kidney (2 BIOCHIPs per field) |
human rat |
IgG IgG IgG |
10 x 05 10 x 10 10 x 50 10 x 05 10 x 10 10 x 50 |
FA 1512-1005-2 FA 1512-1010-2 FA 1512-1050-2 FB 1512-1005-2 FB 1512-1010-2 FB 1512-1050-2 |
|
| IIFT | cell nuclei (ANA) | HEp-2 cells | human | IgG IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1520-1005 FA 1520-1010 FA 1520-1050 FA 1520-12010 FA 1520-2005 FA 1520-2010 FB 1520-1005 FB 1520-1010 FB 1520-1050 FB 1520-2005 FB 1520-2010 |
|
| IIFT | cell nuclei (ANA) | HEp-20-10 cells | human | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1522-1005 FA 1522-1010 FA 1522-2005 FA 1522-2010 FB 1522-1005 FB 1522-1010 FB 1522-2005 FB 1522-2010 |
|
| IIFT | dsDNA | flagellates | Crithidia luciliae | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1572-1005 FA 1572-1010 FA 1572-2005 FA 1572-2010 FB 1572-1005 FB 1572-1010 FB 1572-2005 FB 1572-2010 |
|
| IIFT | dsDNA (sensitive) | flagellates | Crithidia luciliae | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1572-1005-1 FA 1572-1010-1 FA 1572-2005-1 FA 1572-2010-1 |
|
| IIFT |
cell nuclei (ANA) EUROPattern cell nuclei (ANA) |
HEp-2 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 24 x 50 10 x 50 20 x 10 |
FC 1510-1005-1 FC 1510-1010-1 FC 1510-12010-1 FC 1510-2005-1 FC 1510-2010-1 FC 1510-2450-1 FW 1510-1050-1 FW 1510-2010-1 |
|
| IIFT |
cell nuclei (ANA) EUROPattern cell nuclei (ANA) |
HEp-20-10 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 10 |
FC 1512-1005-1 FC 1512-1010-1 FC 1512-1050-1 FC 1512-12010-1 FC 1512-2005-1 FC 1512-2010-1 FC 1512-2450-1 FW 1512-1005-1 FW 1512-1010-1 FW 1512-1050-1 FW 1512-2010-1 |
|
| IIFT |
cell nuclei (ANA) EUROPattern mitochondria (AMA) |
HEp-20-10 cells kidney (2 BIOCHIPs per field) |
human rat |
IgG PI IgG PI IgG PI |
10 x 05 120 x 10 |
FC 1512-1005-2 FC 1512-12010-2 FC 1512-2450-2 |
|
| IIFT |
cell nuclei (ANA) EUROPattern |
HEp-2 cells | human | IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FC 1520-1005 FC 1520-1010 FC 1520-1050 FC 1520-12010 FC 1520-2005 FC 1520-2010 FC 1520-2450 FW 1520-1005 FW 1520-1010 FW 1520-1050 FW 1520-2005 FW 1520-2010 |
|
| IIFT |
cell nuclei (ANA) EUROPattern |
HEp-20-10 cells | human | IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 10 x 05 20 x 05 20 x 10 |
FC 1522-1005 FC 1522-1010 FC 1522-1050 FC 1522-12010 FC 1522-2005 FC 1522-2010 FW 1522-1005 FW 1522-2005 FW 1522-2010 |
|
| IIFT |
dsDNA EUROPattern |
flagellates | Crithidia luciliae | IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1572-1005 FC 1572-1010 FC 1572-2005 FC 1572-2010 |
|
| IIFT |
dsDNA (sensitive) EUROPattern |
flagellates | Crithidia luciliae | IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 |
FC 1572-1005-1 FC 1572-1010-1 FC 1572-12010-1 FC 1572-2005-1 FC 1572-2010-1 |
|
| ELISA | Anti-Histones ELISA (IgG) |
antigen-coated microplate wells |
native, highly purified histones, bovine thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1560-9601 G |
| ELISA |
Anti-dsDNA ELISA (IgG) double-stranded DNA |
antigen-coated microplate wells |
highly purified genomic double-stranded DNA |
10/100/800 IU/ml | IgG |
96 x 01 |
EA 1571-9601 G |
| ELISA | Anti-dsDNA-NcX ELISA (IgG) |
antigen-coated microplate wells |
highly purified genomic double-stranded DNA, complexed with nucleosomes |
10/100/800 IU/ml | IgG |
96 x 01 |
EA 1572-9601 G |
| ELISA | Anti-Nucleosomes ELISA (IgG) |
antigen-coated microplate wells |
native, nucleosomes, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1574-9601 G |
| ELISA |
Anti-ENA SLE Profile 2-ELISA (IgG) (dsDNA, histones, nucleosomes, nRNP/Sm, Sm, SS-A, SS-B, Scl-70 separately) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
12 x 08 |
EA 1590-1208-12 G |
| ELISA |
Anti-ENA ProfilePlus 2 ELISA (IgG) (ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1, centromeres, separately) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
12 x 08 |
EA 1590-1208-2 G |
| ELISA |
ANA Screen 11 ELISA (IgG) (antigen mixture: PCNA, PM-Scl, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1, centromeres) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-11 G |
| ELISA |
ANA Screen 9 ELISA (IgG) (antigen mixture: PCNA, PM-Scl, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-14 G |
| ELISA |
ANA Screen ELISA (IgG) (antigen mixture: dsDNA, histones, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1, centromeres) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-8 G |
| ELISA |
Anti-ENA Pool ELISA (IgG) (antigen mixture: nRNP/Sm, Sm, SS-A, SS-B, Scl-70, ribosomal P-proteins, Ro-52) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-9 G |
| ELISA | Anti-Sm ELISA (IgG) |
antigen-coated microplate wells |
native, U2-, U4-, U5-, U6-nRNP, incl. B, B', D, E, F, G, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1593-9601 G |
| EUROLINE |
EUROLINE ANA Profile 23 (IgG) (nucleosomes, dsDNA, histones, SS-A, Ro-52, SS-B, nRNP/Sm, Sm, Mi-2 alpha, Mi-2 beta, Ku, CENP A, CENP B, Sp100, PML, Scl-70, PM-Scl100, PM-Scl75, RP11, RP155, gp210, PCNA, DFS70 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-23 G DL 1590-5001-23 G DL 1590-6401-23 G |
||
| EUROLINE |
EUROLINE ANA Profile 3 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-3 G DL 1590-5001-3 G DL 1590-6401-3 G |
||
| EUROLINE |
EUROLINE ANA Profile 3 plus DFS70 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2, DFS70 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-30 G DL 1590-5001-30 G DL 1590-6401-30 G |
||
| EUROLINE |
EUROLINE ANA Profile et Mi-2 et Ku (IgG) (Mi-2, Ku, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2 separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-31 G DL 1590-6401-31 G |
||
| EUROLINE |
EUROLINE ANA Profile et Mi-2, Ku, DFS70 (IgG) (Mi-2, Ku, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl100, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2, DFS70 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-33 G DL 1590-5001-33 G DL 1590-6401-33 G |
||
| EUROLINE |
EUROLINE ANA Profile 5 (IgG) (nRNP/Sm, Sm, RNP70, RNPA, RNPC, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2 separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-5 G DL 1590-6401-5 G |
||
| EUROLINE |
EUROLINE ANA-Profile 1 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1, CENP B, dsDNA, nucleosomes, histones, ribosomal P-proteins separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-8 G DL 1590-5001-8 G DL 1590-6401-8 G |
||
| ChLIA | IDS ANA Screen | antigenic coated magnetic particles | dsDNA, Centromere B, SS-A/Ro (60 kDa and 52 kDa), SS-B/La, Sm, U1-snRNP (70 kDa, A and C), Scl-70, Jo-1 |
qualitative |
100 x 01 |
IS-AI10011 | |
| ChLIA | IDS ENA Screen | antigenic coated magnetic particles | SS-A/Ro (60 kDa and 52 kDa), SS-B/La, Sm, U1-snRNP (70 kDa, A and C), Scl-70, Jo-1 |
qualitative |
100 x 01 |
IS-AI10021 | |
| ChLIA | IDS ANA Screen Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI10301 | ||
| ChLIA | IDS dsDNA IgG | antigenic coated magnetic particles | dsDNA |
quantitative |
100 x 01 |
IS-AI11011 | |
| ChLIA | IDS SS-A/Ro | antigenic coated magnetic particles | SS-A/Ro |
quantitative |
50 x 01 |
IS-AI11021 | |
| ChLIA | IDS SS-A/Ro 60 kDa | antigenic coated magnetic particles | SS-A/Ro 60 kDa |
quantitative |
50 x 01 |
IS-AI11041 | |
| ChLIA | IDS SS-B/La | antigenic coated magnetic particles | SS-B/La |
quantitative |
50 x 01 |
IS-AI11051 | |
| ChLIA | IDS Sm | antigenic coated magnetic particles | Sm |
quantitative |
50 x 01 |
IS-AI11061 | |
| ChLIA | IDS U1-snRNP | antigenic coated magnetic particles | U1-snRNP (70 kDa, A, C) |
quantitative |
50 x 01 |
IS-AI11071 | |
| ChLIA | IDS ANA Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI11301 | ||
| ELISA | Anti-ribosomal P Proteins ELISA (IgG) |
antigen-coated microplate wells |
native, P0/P1/P2 of the 60S ribosomal subunit, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1641-9601 G |
|
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC. 1 Product manufactured by third party. Please contact your local Euroimmun representative for more information. | |||||||